PR Newswire
WARSAW, Ind., Feb. 8, 2024
WARSAW, Ind., Feb. 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2023. The Company reported fourth quarter net sales of $1.940 billion, an increase of 6.3% over the prior year period, and an increase of 6.1% on a constant currency1 basis. Net sales for the full year were $7.394 billion, an increase of 6.5% over the prior year, and an increase of 7.5% on a constant currency1 basis. Net earnings for the fourth quarter were $419.2 million, or $458.1 million on an adjusted1 basis. For the full year, net earnings were $1.024 billion, or $1.584 billion on an adjusted1 basis.
Diluted earnings per share were $2.01 for the fourth quarter, and adjusted1 diluted earnings per share were $2.20. Full-year diluted earnings per share were $4.88, and adjusted1 diluted earnings per share were $7.55.
| | | | | | | |
1. | Reconciliations of these measures to the corresponding U.S. generally accepted accounting principles measures are included in this press release. |
"We are pleased to conclude a very successful year with strong fourth quarter results driven by consistent execution, including a healthy second-half growth profile," said Ivan Tornos, Zimmer Biomet's President and Chief Executive Officer. "I'm confident in our ability to carry our 2023 momentum into 2024 and to create further value for our stakeholders. As we look ahead, we remain laser focused on our priorities to advance people and culture, achieve operational excellence and drive innovation and diversification to deliver on our Mission."
Recent Highlights
Kurzfristig positionieren in Zimmer Holdings | ||
ME42R5
| Ask: 0,18 | Hebel: 7,81 |
mit moderatem Hebel |
Zum Produkt
| |
Aligned with the ongoing transformation of Zimmer Biomet's business, key recent highlights include:
Geographic and Product Category Sales
The following sales tables provide results by geography and product category for the three-month period and year ended December 31, 2023, as well as the percentage change compared to the applicable prior year period, on both a reported basis and a constant currency basis.
NET SALES - THREE MONTHS ENDED DECEMBER 31, 2023 | |||||||||||||
(in millions, unaudited) | | | |||||||||||
| | | | | | | | | | | |||
| | | | | | | | | | | |||
| | | | | | | | Constant | | | |||
| Net | | | | | | | Currency | | | |||
| Sales | | | % Change | | | | % Change | | | |||
Geographic Results | | | | | | | | | | | |||
United States | $ | 1,128.2 | | | | 4.4 | | % | | | 4.4 | | % |
International | | 811.9 | | | | 9.1 | | | | | 8.7 | | |
Total | $ | 1,940.1 | | | | 6.3 | | % | | | 6.1 | | % |
Product Categories | | | | | | | | | | | |||
Knees | | | | | | | | | | | |||
United States | $ | 471.5 | | | | 5.4 | | % | | | 5.4 | | % |
International | | 326.8 | | | | 6.7 | | | | | 5.8 | | |
Total | | 798.3 | | | | 5.9 | | | | | 5.6 | | |
Hips | | | | | | | | | | | |||
United States | | 263.3 | | | | 4.0 | | | | | 4.0 | | |
International | | 241.5 | | | | 2.5 | | | | | 3.2 | | |
Total | | 504.8 | | | | 3.3 | | | | | 3.6 | | |
S.E.T. * | | 453.3 | | | | 6.9 | | | | | 6.4 | | |
Other | | 183.7 | | | | 15.8 | | | | | 15.9 | | |
Total | $ | 1,940.1 | | | | 6.3 | | % | | | 6.1 | | % |
| | | | | | | | | | | |||
| | | | | | | | | | | |||
* Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic | | |
NET SALES - YEAR ENDED DECEMBER 31, 2023 | ||||||||||||
(in millions, unaudited) | ||||||||||||
| | | | | | | | | | |||
| | | | | | | | | | |||
| | | | | | | Constant | | | |||
| Net | | | | | | Currency | | | |||
| Sales | | | % Change | | | % Change | | | |||
Geographic Results | | | | | | | | | | |||
United States | $ | 4,288.8 | | | | 6.9 | | % Werbung Mehr Nachrichten zur Zimmer Holdings Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. |